Enhertu received backing from an EU committee for early breast cancer.
Further verified details were not immediately available.
Enhertu receives EU committee backing for early breast cancer
Enhertu has been backed by an EU committee for use in early breast cancer, according to the announcement.
PA
Priya Anand · Equities & Earnings Desk · 21 Sept 2026 · 06:26 · 1 min read
This article was produced with AI assistance and edited by a Finance Review Daily journalist.
ADVERTISEMENT
PA
Written by
Priya Anand
Equities & Earnings Desk
Priya covers listed equities and corporate earnings, reading quarterly results and guidance for what they signal about sector health and forward valuations.
More from Priya Anand →
